CRM Trial Connect 2023

CRM Trial Connect is now on its 2nd year, with more interesting program content developed for participating clinical research stakeholders!

Minister of Health Engages with Malaysian Researchers and Medical Experts in the UK for Clinical Research Collaboration

London, 29 January 2023  – The UK-Malaysia Clinical Research Partnership forum organised by Clinical Research Malaysia, was successfully wrapped up on Sunday. The event took place at Malaysia Hall, London and had over 80 attendees in the field of clinical research participating. Most of the attendees were part of prestigious universities, industry and hospitals who came from areas of Oxford, Cambridge, Manchester, Plymouth as well as Sheffield. The forum was also graced by both Malaysia’s Minister of Health, Dr Zaliha Mustafa and Director General of Health, Tan Sri Dato Seri Dr Noor Hisham Abdullah.

With the theme ‘Making It Happen’, the forum’s objective was to bring Malaysian clinical researchers in the UK together to discuss about the areas of research interest that can be explored together with Ministry of Health Malaysia. “We hope to leverage on the Malaysian diaspora in the UK to form collaborative research with our local researchers and clinicians back home. With more than 1000 active and experienced clinical trialists in Malaysia delivering quality research in their respective institution, I believe that with the right partnerships we could leverage on common research interests and areas between both countries and make these projects happen”, said Dr Zaliha in her opening address.

The forum was moderated by Professor Eric Lim, Consultant Thoracic Surgeon from the Royal Brompton Hospital and panellists include Associate Professor Dr Masliza from University of Oxford, Dr Joseph Cheriyan from University of Cambridge, Dr Azlisham Mohd Nor from University Hospital Plymouth, Dr Nubli Mustafa from AstraZeneca Cambridge and Dr Ezanul Wahab from MAC Clinical Research. The panel members shared their research experiences and insights on the current and future collaboration in their field of expertise.

In closing the forum, Tan Sri Dato’ Seri Dr Noor Hisham, Director-General of Health also shared his aspiration in hoping these partnerships would enable knowledge transfer between researchers in both nations in addition to further building the research expertise in Malaysia through training and development programs.

Malaysia unlocks a new collaboration with Canada’s Princess Margaret Cancer Centre

Toronto, 7 December 2022 – Clinical Research Malaysia (CRM) achieved a new collaborative milestone today with the signing of a Memorandum of Understanding (MoU) with the Princess Margaret Cancer Centre (PMCC). PMCC is one of the top 5 and largest cancer research centres in the world and focuses on all three areas of research: basic, translational and clinical research.

The inking of this MoU spells cooperation in the area of clinical, academic and research opportunities at both organizations. This will also entail education and training opportunities including fellowship attachments, staff and patient education. Other initiatives also aimed at promoting and enabling collaboration, innovation and knowledge exchange to advance cancer care control in both countries.

This collaboration is significant especially in providing fellowship training opportunities for Malaysian oncologists as well as for research nurses and study coordinators to gain the needed experience and exposure in first-in-human and early phase clinical research. The MoU with PMCC is in line with CRM’s Phase 1 Realisation Project to further develop the country’s human capability development in early phase clinical research conduct to enable the country attract more global early phase studies.

The MoU was witnessed by the Director-General of Health Malaysia, Tan Sri Dato’ Seri Dr. Noor Hisham and signed by Dr Akhmal Yusof, CEO of CRM and Dr Keith Stewart, Vice President, Cancer and Medical Director of the Princess Margaret Cancer Program, UHN who is also the Regional Vice-President, Toronto Central South Regional Cancer Program, Ontario Health.

Prior to the signing ceremony, Tan Sri Dato’ Seri Dr Noor Hisham gave a Grand Round Presentation that saw the participation of the leadership team of PMCC. “The cementing of this MOU with PMCC is important to build bridges and strengthen our collaboration in training, education and clinical services. We believe by opening one door, there will be multiple other doors and opportunities for us to explore in the future. Clinical research is a key pillar in the MOH. I look forward to see our engagements bridge the gap between both countries, strengthen the resources that we have and make a significant diffe

Notification of Legal Review Fees

Dear Valued Clients

We wish to inform you that the CRM Legal Review Fee Charges are as follows:

Name of Fees Charges
Sponsored Research (SR) Initial CTA Review MYR 4,000
Investigator Initiated Research (IIR) Initial CTA Review MYR 2,000
BABE Initial CTA Review MYR 2,000
Each Additional Site CTA Review MYR 500
Each Amendment per occurrence Review MYR 100


Note: Above fees and charges are chargeable with 6% Sales and Services Tax (SST).

For further information, please do not hesitate to contact CRM Legal & Regulatory Affairs Department at Tel: +603 7931 5566/Email:

We thank you for your continuous support.

Global First Recruiter – Hospital Ampang

Congratulations Dr Veena Selvaratnam (Hospital Ampang) on being the 1st Global recruiter in a multinational hematology study.

CRM Observes the Movement Control Order (MCO), Conditional MCO & Recovery MCO

CRM observes the Movement Control Order (MCO), Conditional MCO & Recovery MCO in effect from 13th January 2020 – 26th January 2020.

Congratulations Hospital Pulau Pinang for outstanding recruitment achievement!

Congratulations Dr Fong Chin Heng and team for an outstanding recruitment achievement and being among the top global enrolling sites in this NSCLC study!